circRNA basic information
circBase ID: hsa_circ_0006949
Name: hsa_circ_GLUL
Synonym: circ_0006949
Host Gene: GLUL
Genomic location(hg19): chr1:182355560-182356265:-
Genomic location(hg38): chr1:182386425-182387130:-
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005061
MONDO name: lung adenocarcinoma
Disease details: lung adenocarcinoma
Disease DO ID:
3910
Disease MeSH ID:
C538231
Disease NCIt ID:
C3512
Disease ICD11 ID:
-
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

sputum specimens; NSCLC tissues; cancer tissue; adjacent cancer tissue; tumor tissues; para-cancerous tissue specimens

Cell lines:

A549; H1299; PC9; H226

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: GLUL, Ago2
Associated microRNA: miR-4673
Biological function: Promotes NSCLC cell proliferation, clone formation, cell cycle progression, migration, invasion, tumor growth, and glutamine-related metabolic activity; inhibits apoptosis signaling.
Molecular mechanism: Circ_0006949 acts as a cytoplasmic ceRNA sponge for miR-4673, preventing miR-4673-mediated repression of GLUL, thereby increasing GLUL expression and catalytic activity, regulating glutamine metabolism and suppressing apoptosis signaling.
Biological pathway or process:

ceRNA regulation (promotes); proliferation (promotes); cell cycle (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); glutaminolysis (other); other pathway/process (promotes)

Detected method:
Q
M
Validation methods:

Microarray; RNase R Treatment; RT-qPCR; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); Transfection; CCK8; EdU Staining; Colony Formation Assay; Cell Cycle Assay; Wound Healing Assay; Transwell Assay; In Vivo Animal Model; IHC (Immunohistochemistry); Western Blot

Clinical significance:

Sputum circ_0006949 is a non-invasive biomarker for early diagnosis and therapeutic monitoring of NSCLC; it has higher diagnostic value than conventional serum markers and decreases after surgery.

Description:

Circ_0006949 is up-regulated in sputum and tumor tissues from NSCLC patients and serves as a potential non-invasive biomarker for early diagnosis and therapeutic monitoring. Functionally, cytoplasmic circ_0006949 promotes NSCLC proliferation, colony formation, migration, invasion and xenograft tumor growth, while suppressing apoptosis signaling. Mechanistically, it acts as a ceRNA for miR-4673 to upregulate GLUL, enhancing GLUL catalytic activity and glutamine-related metabolism.

Confidence score:

0.8457

Other information
Title:

Circ_0006949 as a potential non-invasive diagnosis biomarker promotes the proliferation of NSCLC cells via miR-4673/GLUL axis.

Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: 2024
PubMed ID: 38750769
Study type:

combined biological and clinical study

Data availability: GSE216785; Supplementary data at https://doi.org/10.1016/j.bbadis.2024.167234
Code availability: -